baber/WOPTO huggingface dataset:
Patent AU-2017442202-A1 (AU)
Title: Rain filtering techniques for autonomous vehicle
Inventor: CHEE YONG WAY
IPC: G01S17/931
Filed: 2017-12-08
Abstract: The invention relates to a system and method for using lidar to navigate an autonomous vehicle during rain or snowy conditions. Two lidar units are used to concurrently scan an area near an autonomous vehicle. The reflected laser light from the two lidar devices is analyzed with an algorithm. Reflected laser light that is not detected by both units can be attributed to rain. The lidar units can use multi-echo scanning. Further, the lidar devices can scan a series of planes (i.e. multi-plane scanning) to improve the robustness of the system. The system improves the reliability of lidar navigation when rain, snow or other particles are present in the air.
Patent WO-2018227249-A1 (WO)
Title: Système de dispersion de fluide pour la suppression d'incendie
Inventor: ERCIFTCI IRFAN
IPC: A62C31/05
Filed: 2018-06-13
Abstract: L'invention concerne un appareil de dispersion de fluide pour la suppression d'incendie, l'appareil comprenant : un ensemble de montage pour monter le système sur un véhicule ; un réseau de buses de pulvérisation ; une structure de support, reliant les buses de pulvérisation à l'ensemble de montage et étant apte à être supportée par lui ; et un réseau d'alimentation en fluide apte à relier fluidiquement les buses de pulvérisation à une alimentation en fluide en utilisation.
Patent WO-2019084621-A1 (WO)
Inventor: CORONEO MINAS THEODORE
IPC: A61K31/4025
Filed: 2018-11-02
Abstract: L'invention concerne une composition pharmaceutique comprenant un antagoniste muscarinique et un antagoniste de l'adénosine destinée à une application topique ou ophtalmique, et des dispositifs ophtalmiques contenant ou administrant celles-ci, et des méthodes d'utilisation de celle-ci, pour réguler et/ou réduire la progression de la myopie.
Patent AU-2018201911-A1 (AU)
Title: Smart grid topology estimator
Inventor: SONDEREGGER ROBERT
IPC: G06Q10/06
Filed: 2018-03-16
Abstract: SMART GRID TOPOLOGY ESTIMATOR Techniques for determining aspects of a topology of a smart grid are described herein, and particularly for determining if one or more electrical meters are connected to the same transformer. In one example, time-stamped voltage data is collected from at least two meters. The voltage data may indicate a slight transient change in voltage resulting from a consumer turning on or off an electrical load. In particular, the slight voltage changes may be sensed by all meters attached to a same transformer based on electrical load changes by any one of the customers on the same transformer. Using the time- stamped voltage data, a time-series of voltage-changes may be generated for each electrical meter. A correlation between the time series of voltage-changes of pairs of meters may be calculated, to thereby determine an affinity between the meters, and particularly if they are connected to a same transformer.
Patent AU-2018203156-A1 (AU)
Title: Shopping cart
Inventor: STAUFF RICK
IPC: B29C45/26
Filed: 2018-05-07
Abstract: A handle assembly for a shopping cart, the shopping cart having a front end and a rear end, the shopping cart including a basket and a rear gate, the handle assembly comprising: a handle positioned proximate the rear end of the shopping cart; and an elongated slot positioned proximate the handle and adapted for supporting an accessory; wherein the handle assembly is configured to support the rear gate for pivoting movement relative to the basket 10246109 1 (GHMatters) P100867.AU.1 coo Q0 co CD C) CD (04 m l CD mD C CDr 8 o m CD C cq 00
Patent AU-2018203477-A1 (AU)
Title: Benzoquinoline inhibitors of VMAT2
Inventor: SOMMER ANDREAS
IPC: A61K31/4375
Filed: 2018-05-17
Abstract: The present invention relates to new benzoquinolone inhibitors of VMAT2, pharmaceutical compositions thereof, and methods of use thereof.
Patent AU-2018211326-A1 (AU)
Title: Medical tubing detection and management
Inventor: ADAMS GRANT
IPC: A61M39/08
Filed: 2018-08-03
Abstract: MEDICAL TUBING DETECTION AND MANAGEMENT A medical tubing set (100) comprising: a fluid conduit (104) adapted to convey a medical fluid; an optical element (102) coupled to the fluid conduit (104) and configured to provide illumination; a power source (110) configured to power the optical element (102); and at least one sensor (106) configured to sense at least one characteristic related to the medical tubing system (100).
Patent AU-2018219308-A1 (AU)
Title: Methods for cell-type specific profiling to identify drug targets
Inventor: HEINTZ NATHANIEL
IPC: C12Q1/68
Filed: 2018-02-09
Abstract: The present invention provides methods of profiling gene and protein expression of a plurality of nuclei from a single cell type and comparing the profiles to determine variability among cell populations, samples from different subjects, and cells expressing a disease phenotype.
Patent AU-2018221322-A1 (AU)
Title: Amino pyrimidine compounds useful as SSAO inhibitors
Inventor: FAN MENGYANG
IPC: A61P1/16
Filed: 2018-02-07
Abstract: The present invention provides compounds of the formula below, pharmaceutically acceptable salts of the compounds, methods of treating patients for liver disease, and processes for preparing the compounds.
Patent AU-2018264038-A1 (AU)
Title: Techniques for l3 pairing and workforce management in a contact center system
Inventor: CHISHTI ZIA
IPC: H04M3/50
Filed: 2018-11-14
Abstract: Techniques for L3 pairing and workforce management in a contact center system are disclosed. In one particular embodiment, the techniques may be realized as a method for L3 pairing in a contact center system comprising identifying a plurality of contacts waiting for assignment, identifying a plurality of agents available for assignment, and selecting at least one of the plurality of agents with at least one of the plurality of contacts for assignment and connection within the contact center system. Contact Center System Central Switch 1-1 L3 Pairing Module Contact Center N, Contact Center A SwiVltch Switch 12___ 120B -Agent Agent -Agent Agent 1-30A 1_3 0B 130C 130D)
Patent AU-2018269302-A1 (AU)
Title: Absorbent article with channels and method for manufacturing thereof
Inventor: SMET STEVEN
IPC: A61F13/475
Filed: 2018-05-14
Abstract: An absorbent article comprising a liquid pervious topsheet, a liquid impervious backsheet, and an absorbent core comprising an absorbent material between a top core wrap sheet and a back core wrap sheet, said absorbent core being positioned in between said topsheet and said backsheet, said absorbent core having a first and second longitudinal edge and a first and second transverse edge, said absorbent core having a first portion (130a), (130b) and a second portion (130b), (130a) on either side of a transverse crotch line (L), wherein the absorbent core is provided with a plurality of attachment zones where the top core wrap sheet is attached to the back core wrap sheet, wherein, measured in a transverse direction, a first maximum distance between a first and a second attachment zone is bigger than a second maximum distance between a third and a fourth attachment zone.
Patent AU-2018271132-A1 (AU)
Title: Valve for large scale irrigation
Inventor: COCCIARDI PETER ANTHONY
IPC: F16K21/04
Filed: 2018-05-15
Abstract: A valve assembly (10) for large scale irrigation including a valve body (20) and a valve head (40). The valve head is adapted to reciprocally travel along a longitudinal axis, supported by a longitudinally aligned shaft (60) inside the valve body. The valve head includes a wall (41) terminating in a peripheral sealing contact surface (42), the wall extending inwardly from the peripheral contacting surface.
Patent AU-2018271420-A1 (AU)
Title: Optimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI)
Inventor: WANG ZHUOZHI
IPC: A61K39/395
Filed: 2018-12-03
Abstract: Optimized Monoclonal Antibodies against Tissue Factor Pathway Inhibitor (TFPI) Abstract Isolated monoclonal antibodies that bind human tissue factor pathway inhibitor (TFPI) are provided. Isolated nucleic acid molecules encoding monoclonal antibodies that bind TFPI are also contemplated. Pharmaceutical compositions comprising the anti-TFPI monoclonal antibodies and methods of treating deficiencies or defects in coagulation by administration of the antibodies are also provided. Methods of producing the antibodies are also provided. H:\fint\Interwoven\NRPortbl\DCC\FMT\12333673 1.docx -9/12/16
Patent AU-2018287525-A1 (AU)
Title: Systems and methods for data encryption for cloud services
Inventor: HUANG FENG
IPC: H04L29/06
Filed: 2018-05-16
Abstract: Systems and methods for secure storage and transmission of sensitive information in a cloud environment. The methods comprise: receiving sensitive information corresponding to a first resource associated with a first cloud, generating an encryption key for encrypting the sensitive information, encrypting the sensitive information using the encryption key, transmitting the encrypted sensitive information to a cloud connector via a first communication channel, and transmitting the encryption key to a configuration service. The configuration service is associated with a second cloud. The method may further comprise, by a cloud connector: receiving the encryption key from the second resource associated with the second cloud and using the encryption key to decrypt the encrypted sensitive information.
Patent AU-2018304547-A1 (AU)
Title: Computing and displaying climb drive marker elevation
Inventor: PEARSON JOHN TIMOTHY
IPC: G06F17/10
Filed: 2018-07-20
Abstract: A method of calculating a climb-dive marker (CDM) that is visibly present on a display even as the aircraft approaches a roll angle of +/- 90° is provided. An exemplary CDM method comprises obtaining, an X-axis velocity, a Y-axis velocity, and a Z-axis velocity in aircraft body coordinates of an aircraft; calculating a CDM elevation; and displaying, by the controller, the calculated CDM elevation. The method can further comprise obtaining an angle of attack (AoA) of the aircraft and a roll angle of the aircraft, wherein the AoA is set as the value of the CDM elevation when the roll angle is within a preset range. The CDM elevation may also be calculated using a combination of the AOA and the CDM formula when roll angle is within a second preset range.
Patent AU-2018311307-A1 (AU)
Title: Crystalline forms of hydroxynorketamine
Inventor: PEARSON DAVID
IPC: A61K31/135
Filed: 2018-07-31
Abstract: The present invention provides novel, stable, processable and pharmaceutically acceptable salt forms of 2R,6R-hydroxynorketamineor 2S,6S-hydroxynorketamine with high aqueous solubility.
Patent AU-2018326734-A1 (AU)
Title: Substituted 2-azabicyclo(3.1.1)heptane and 2-azabicyclo(3.2.1)octane derivatives as orexin receptor antagonists
Inventor: MICHELI FABRIZIO
IPC: A61P25/30
Filed: 2018-08-31
Abstract: There is provided a compound of formula (I), wherein L
Patent AU-2018332512-A1 (AU)
Title: Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
Inventor: ALTENBACH ROBERT J
IPC: C07D231/56
Filed: 2018-09-13
Abstract: The invention discloses compounds of Formula (I), wherein A
Patent AU-2018352137-A1 (AU)
Title: Sterilization arrangement for drug delivery device
Inventor: FALKOVICH MARGARITA
IPC: A61M5/00
Filed: 2018-10-15
Abstract: A drug delivery system for injecting a medicament includes a housing defining a cavity, a container received within the cavity and configured to receive a medicament, the container comprising a stopper configured to move within the container and a closure, a drive assembly received within the cavity and configured to drive the stopper within the container, a needle actuator assembly received within the cavity and comprising a needle configured to be placed in fluid communication with the container, the needle moveable from a first position and a second position spaced from the first position, and a sterilizer received within the cavity and configured to sterilize at least one of the container, the drive assembly, and the needle actuator assembly upon activation of the drug delivery system.
Patent AU-2018362632-A1 (AU)
Title: Cryoprobe for magnetic resonance imaging
Inventor: KOLLMANN DANIEL
IPC: H01F27/34
Filed: 2018-11-07
Abstract: A cryoprobe is disclosed comprising a probe shaft made of a low magnetic susceptibility material and an electrical resistance heater comprising counter-wound helical coils located within the probe shaft. The counter-wound helical coils are formed by a single wire counter- wound to form a first set of coils wound in a direction counter to a second set of coils, such that when current is supplied to the electrical resistance heater, a first magnetic field generated by the first set of coils is opposite to a second magnetic field generated by the second set of coils. The electrical resistance heater can heat, thaw, and/or cauterize tissue. The electrical resistance heater can be made of a low magnetic susceptibility material so as to resistively heat tissue concurrently during magnetic resonance imaging (MRI). A method of electrically heating a tissue in conjunction with MRI, and a method of imaging a cryoprobe using MRI is also disclosed.
Patent AU-2018368769-A1 (AU)
Title: Polymer agonists of mu opioid receptors
Inventor: MAIONE THEODORE E
IPC: A61P29/00
Filed: 2018-11-19
Abstract: The subject invention provides compositions and methods for alleviating pain. Specifically, the subject invention provides pharmaceutical formulations of polymers, and/or their salts, having advantageous μ-opioid receptor binding activity.
Patent AU-2018370536-A1 (AU)
Title: Method and system for funding entertainment machines
Inventor: RATIK MARTIN
IPC: A63F13/71
Filed: 2018-11-16
Abstract: A method executed by a payment console, the method including: receiving user input for making a payment for one or more entertainment machines; determining a payment amount based on the user input; sending to a transaction module a payment request containing the payment amount; receiving, from the transaction module, a payment confirmation message; and, as a result of receiving the payment confirmation message from the transaction module or generating a positive credit result in response to a credit verification request from a credit receiver device connected to an entertainment machine, communicating, via wireless communication, credit information to the credit receiver device to enable operation of the entertainment machine.
Patent AU-2018379306-A1 (AU)
Title: Combination therapy of multiple sclerosis comprising a CD20 ligand
Inventor: WIECZOREK MACIEJ
IPC: C07K16/28
Filed: 2018-12-05
Abstract: The present invention relates to the use of a CD20 ligand and at least one further active agent in the treatment of multiple sclerosis, to the use of a pharmaceutical composition and to a kit comprising the CD20 ligand and at least one further active agent or a pharmaceutical composition comprising such CD20 ligand and further active ingredient.
Patent WO-2019144186-A1 (WO)
Title: Expression vector and method
Inventor: LAYTON CHRISTOPHER
IPC: A61K48/00
Filed: 2019-01-23
Abstract: The present disclosure relates to regulatable expression vectors for systematically controlling and silencing expression of a therapeutic molecule and uses thereof, e.g. treating ocular disorders such as choroidal neovascularisation.
Patent AU-2019201091-A1 (AU)
Title: Multiple co-frequency microwaves detection antenna, manufacture method thereof and detection method thereof
Inventor: ZOU GAODI
IPC: H01Q21/00
Filed: 2019-02-15
Abstract: A multiple co-frequency microwaves detection antenna includes an oscillation circuit unit, a 
reference ground and at least two radiation sources. The radiation sources each has a feed point 
and are arranged spacedly at the reference ground. A radiation gap is formed between each of the 
radiation sources and the reference ground. The feed point of the radiation source is electrically 
connected to the oscillating circuit unit.
70 
71 
51 
50 
20 21 
Fig.14A 
60 
70 
Fi-g1 
Fig. 14B
Patent AU-2019201961-A1 (AU)
Title: System for content-aware vector path creation from raster image data
Inventor: PETERSON JOHN
IPC: G06T5/00
Filed: 2019-03-20
Abstract: The present disclosure describes one or more embodiments of a selective raster image transformation system that quickly and efficiently generates enhanced digital images by selectively transforming edges in raster images to vector drawing segments. In particular, the selective raster image transformation system efficiently utilizes a content-aware, selective approach to identify, display, and transform selected edges of a raster image to a vector drawing segment based on sparse user interactions. In addition, the selective raster image transformation system employs a prioritized pixel line stepping algorithm to generate and provide pixel lines for selective edges of a raster image in real time, even on portable client devices. 100-14 Generating An Edge Map For A Raster Image 102 Detecting A First User Interaction With An Edge In The Raster Image 104 Generating A Pixel Line Using The Edge Map 106 Displaying The Pixel Line Over The Raster Image 108 Render A Vector Drawing Segment Fitted To The Pixel Line110 Fig. I
Patent AU-2019202535-A1 (AU)
Title: Cover assembly and methods
Inventor: SAY CHRISTOPHER J
IPC: E04F17/00
Filed: 2019-04-11
Abstract: Systems and methods of installing a fixture into a material are provided. The fixture includes a body and a cover assembly that is removably coupled to the body and configured to move relative to the body once the body has been secured within the material. The cover assembly includes a movable component configured to aid removal of the cover assembly. -88 ,-42 E _ _ _ _ _ __ _ _ _ _ _ __ _ _ _ _ _ y-36 no_ __ - __ _ _ FIG. 2 ____________________________ 28 _ _ _ _ __ _ _ < 22
Patent AU-2019203416-A1 (AU)
Title: Application deployment
Inventor: JOUHIER BRUNO CLAUDE JEAN-MARIE
IPC: G06F8/61
Filed: 2019-05-15
Abstract: Abstract A method of deploying an application. The method comprises: publishing a first code package to a package registry; publishing one or more further code 5 packages to the package registry; assembling application source code by combining the first code package with one or more of the further code packages from the package registry in accordance with dependencies specified in an application manifest file. The first code package comprises code specifying a first definition of a class and at least one of the one or more further code packages 10 comprises code specifying a further definition of the class. The further definition of the class comprises prototype merging so that on compilation the first definition of the class and the extended definition of the class are loaded as a single class, and module augmentation so that the first and extended definitions of the class are treated as a single merged class by development tools. Figure 4 for publication 106 107 108 Application developer User 1 User 2 User 3 Cloud Platform Third party Third party Third party developer developer developer 103 104 105 Fig 1
Patent AU-2019203421-A1 (AU)
Title: Animation sequence associated with feedback user-interface element
Inventor: MATAS MICHAEL
IPC: G06F3/14
Filed: 2019-05-15
Abstract: ANIMATION SEQUENCE ASSOCIATED WITH FEEDBACK USER INTERFACE ELEMENT In one embodiment, a content item and a feedback user-interface (UI) element associated with the content item may be displayed on a user device. The feedback UI element enables a user to provide feedback with respect to the content item. In response to a user interaction with the feedback UI element, an animation sequence featuring the feedback UI element is displayed on the user device. - - - - - - ---- -- -- --- u- -------------------------------- -- - - ----- 1 "Mis SAhN -- -- - -- - ------- -%e I~ gl
Patent AU-2019214836-A1 (AU)
Title: Stable wound healing ointment
Inventor: KRAUSE-KYORA FELIX
IPC: A61K8/37
Filed: 2019-01-29
Abstract: The invention relates to a stable cosmetic or dermatological formulation, in particular a wound healing ointment, which contains a.) 0.8 to 3 wt.-%, in particular 1.2 to 1.8 wt.-% glyceryl stearates, b.) 0.8 to 3 wt.-%, in particular 1.2 to 1.8 wt.-% glyceryl stearates SE, c.) one or more lipids selected from the group including ceresin, cera microcristallina and paraffinum liquidum, advantageously 8 to 12 wt.-%, in particular 9 to 11 wt.-% ceresin, d.) less than 1 wt.-% water, and e.) less than 0.1 wt.-% of each of cholesterol and lanolin alcohol.
Patent AU-2019219061-A1 (AU)
Title: Antibodies binding to GPRC5D
Inventor: FERTIG GEORG
IPC: A61P35/00
Filed: 2019-02-07
Abstract: The present invention generally relates to antibodies that bind to GPRC5D, including bispecific antigen binding molecules e.g. for activating T cells. In addition, the present invention relates to polynucleotides encoding such antibodies, and vectors and host cells comprising such polynucleotides. The invention further relates to methods for producing the antibodies, and to methods of using them in the treatment of disease.
Patent AU-2019225740-A1 (AU)
Title: Antibody variable domains targeting CD33, and use thereof
Inventor: CHANG GREGORY P
IPC: A61K35/17
Filed: 2019-02-20
Abstract: Disclosed are proteins with antibody heavy chain and light chain variable domains that can be paired to form an antigen binding site targeting CD33 (Siglec-3) on a cell, pharmaceutical compositions comprising such proteins, and therapeutic methods using such proteins and pharmaceutical compositions, including for the treatment of cancer.
Patent AU-2019257492-A1 (AU)
Title: Novel compositions and methods for the treatment of immune related diseases
Inventor: CLARK HILARY
IPC: C07K14/705
Filed: 2019-10-31
Abstract: The present invention relates to compositions and methods of using those compositions for the diagnosis and treatment of immune related diseases. 11832255_1 (GHMatters) P85193.AU.3 F-fe C3-C C3 ko - ? .C-. A bA-d r
Patent AU-2019272964-A1 (AU)
Title: Amino-pyrazinecarboxamide compounds, conjugates, and uses thereof
Inventor: SMITH SEAN WESLEY
IPC: C07D401/14
Filed: 2019-05-24
Abstract: Amino-pyrazinecarboxamide compounds of formula (I), conjugates, and pharmaceutical compositions for use in the treatment of disease such as cancer, are disclosed herein. The disclosed compounds are useful, among other things, in the treating of cancer and fibrosis and modulating TGFpR2. Additionally, compounds incorporated into a conjugate with an antibody construct are described herein.
Patent AU-2019294838-A1 (AU)
Title: Compounds and methods for reducing LRRK2 expression
Inventor: COLE TRACY A
IPC: C12N15/113
Filed: 2019-06-27
Abstract: Provided are compounds, methods, and pharmaceutical compositions for reducing the amount or activity of LRRK2 RNA in a cell or animal, and in certain instances reducing the amount of LRRK2 protein in a cell or animal. Such compounds, methods, and pharmaceutical compositions are useful to ameliorate at least 5 one symptom or hallmark of a neurodegenerative disease. Such symptoms and hallmarks include ataxia, neuropathy, and aggregate formation. Such neurodegenerative diseases include Parkinson's disease.